These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9058614

  • 1. Cidofovir: a new therapy for cytomegalovirus retinitis.
    Lalezari JP.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S22-6. PubMed ID: 9058614
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
    Lalezari JP, Kuppermann BD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S27-31. PubMed ID: 9058615
    [Abstract] [Full Text] [Related]

  • 3. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
    Lalezari JP, Drew WL, Glutzer E, James C, Miner D, Flaherty J, Fisher PE, Cundy K, Hannigan J, Martin JC.
    J Infect Dis; 1995 Apr; 171(4):788-96. PubMed ID: 7706804
    [Abstract] [Full Text] [Related]

  • 4. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Ann Intern Med; 1997 Feb 15; 126(4):264-74. PubMed ID: 9036798
    [Abstract] [Full Text] [Related]

  • 5. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
    Lalezari JP, Holland GN, Kramer F, McKinley GF, Kemper CA, Ives DV, Nelson R, Hardy WD, Kuppermann BD, Northfelt DW, Youle M, Johnson M, Lewis RA, Weinberg DV, Simon GL, Wolitz RA, Ruby AE, Stagg RJ, Jaffe HS.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr 01; 17(4):339-44. PubMed ID: 9525435
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
    Wolf DL, Rodríguez CA, Mucci M, Ingrosso A, Duncan BA, Nickens DJ.
    J Clin Pharmacol; 2003 Jan 01; 43(1):43-51. PubMed ID: 12520627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul 28; 14(11):1571-81. PubMed ID: 10983644
    [Abstract] [Full Text] [Related]

  • 9. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
    Chavez-de la Paz E, Arevalo JF, Kirsch LS, Munguia D, Rahhal FM, De Clercq E, Freeman WR.
    Ophthalmology; 1997 Mar 28; 104(3):539-44. PubMed ID: 9082286
    [Abstract] [Full Text] [Related]

  • 10. Cidofovir.
    Bowers M.
    BETA; 1998 Jul 28; ():41-2. PubMed ID: 11365563
    [Abstract] [Full Text] [Related]

  • 11. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
    Plosker GL, Noble S.
    Drugs; 1999 Aug 28; 58(2):325-45. PubMed ID: 10473024
    [Abstract] [Full Text] [Related]

  • 12. Cidofovir approved.
    PI Perspect; 1996 Sep 28; (No 19):14-5. PubMed ID: 11363898
    [Abstract] [Full Text] [Related]

  • 13. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS, Arevalo JF, De Clercq E, Chavez de la Paz E, Munguia D, Garcia R, Freeman WR.
    Am J Ophthalmol; 1995 Apr 28; 119(4):466-76. PubMed ID: 7709971
    [Abstract] [Full Text] [Related]

  • 14. Nursing considerations in the use of cidofovir for CMV retinitis in patients with AIDS: report of a roundtable meeting.
    Martin MA, Kane C.
    J Assoc Nurses AIDS Care; 1997 Apr 28; 8(5):66-74. PubMed ID: 9298471
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, de Clercq E, Freeman WR.
    Ophthalmology; 1995 Apr 28; 102(4):533-42; discussion 542-3. PubMed ID: 7724170
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
    Rahhal FM, Arevalo JF, Munguia D, Taskintuna I, Chavez de la Paz E, Azen SP, Freeman WR.
    Ophthalmology; 1996 Jul 28; 103(7):1078-83. PubMed ID: 8684797
    [Abstract] [Full Text] [Related]

  • 17. Cidofovir (HPMPC) potent against CMV.
    Posit Aware; 1995 Jul 28; ():5. PubMed ID: 11362567
    [Abstract] [Full Text] [Related]

  • 18. Recurrent iritis after intravenous administration of cidofovir.
    Palau LA, Tufty GT, Pankey GA.
    Clin Infect Dis; 1997 Aug 28; 25(2):337-8. PubMed ID: 9332544
    [No Abstract] [Full Text] [Related]

  • 19. New developments in the treatment of CMV retinitis.
    Freeman WR.
    Ophthalmology; 1996 Jul 28; 103(7):999-1000. PubMed ID: 8684813
    [No Abstract] [Full Text] [Related]

  • 20. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group..
    Am J Ophthalmol; 2001 Apr 28; 131(4):457-67. PubMed ID: 11292409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.